sitagliptin glp 1 agonist Frontiers Sitagliptin/Metformin (Janumet) as Combination Therapy
Description
It activates GLP-1 receptors, leading to increased insulin release from pancreatic beta cells in response to elevated blood sugar levels, making it an excellent treatment for type 2 diabetes
For a deeper dive into related GLP-1 side effects, read our guide to why GLP-1 medications cause GI issues
A similar pattern was observed for pancreatic cancer
As shown in Scheme 33
J., Akerstrom V., Pan W
S7B, C)
